Supernus Pharmaceuticals, Inc.
SUPNDrug Manufacturers - Specialty & Generic
$41.84+1.85%As of Oct 29vs prior close
- Market cap
- $2.4B
- P/E (TTM)
- –
- From 52W high
- −26.60%
- EPS (LTM)
- -$0.77
- Revenue (LTM)
- $865.1M
- Net margin
- -5.07%
- Dividend yield
- 0.00%
Nomior Score
39
Steady ProfileSpeculativeBottom 27% of the scored universe
Growth64
Quality45
Value51
Momentum12
Resilience50
Growth
+14.35%revenue a year over 9 fiscal years
FY16 $215MLTM $865.1M
Connections
Revenue to profitQ3 FY26
9% of revenue became net profit, up 33 pts on a year.
Who owns it
2funds, 1 tracked portfolio